液相色谱-质谱联用法测定血浆中fostemsavir含量的验证

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Siddhartha Lolla , Kumar Shiva Gubbiyappa , Shankar Cheruku , D.V.R.N. Bhikshapathi
{"title":"液相色谱-质谱联用法测定血浆中fostemsavir含量的验证","authors":"Siddhartha Lolla ,&nbsp;Kumar Shiva Gubbiyappa ,&nbsp;Shankar Cheruku ,&nbsp;D.V.R.N. Bhikshapathi","doi":"10.1016/j.vascn.2023.107254","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>A novel, sensitive and specific LC-MS/MS technique was developed and validated for the quantification of fostemsavir in human plasma and its pharmacokinetic application in rabbits.</p></div><div><h3>Methods</h3><p>Chromatographic separation of the fostemsavir and fosamprenavir (internal standard) were achieved on Zorbax C18 (50 mm × 2 mm × 5 μm) column with 0.80 mL/min flow rate and coupled with API6000 triple quadrupole MS in multi reaction monitoring mode by applying mass transitions <em>m</em>/<em>z</em> 584.16/105.03 for fostemsavir and m/z 586.19/57.07 for the internal standard.</p></div><div><h3>Results</h3><p>The calibration curve exhibited linearity in concentration range of 58.5–2340.0 ng/mL for fostemsavir. The LLOQ was 58.5 ng/mL. The validated LC–MS/MS process was effectively applied for the analysis of plasma in healthy rabbits for determinations of Fostemsavir. From the pharmacokinetic data, the mean of C<sub>max</sub> and T<sub>max</sub> were 198.19 ± 5.85 ng/mL and 2.42 ± 0.13, respectively. Plasma concentration reduced with t<sub>1/2</sub> of 7.02 ± 0.14. AUC<sub>0→Last</sub> value obtained was 2374.87 ± 29.75 ng. h/ml, respectively.</p></div><div><h3>Conclusion</h3><p>In summary, the developed method has been successfully validated and pharmacokinetic parameters were demonstrated after oral administration of Fostemsavir to healthy rabbits.</p></div>","PeriodicalId":16767,"journal":{"name":"Journal of pharmacological and toxicological methods","volume":"120 ","pages":"Article 107254"},"PeriodicalIF":1.3000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Validation of an LC–MS/MS method for quantitation of fostemsavir in plasma\",\"authors\":\"Siddhartha Lolla ,&nbsp;Kumar Shiva Gubbiyappa ,&nbsp;Shankar Cheruku ,&nbsp;D.V.R.N. Bhikshapathi\",\"doi\":\"10.1016/j.vascn.2023.107254\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>A novel, sensitive and specific LC-MS/MS technique was developed and validated for the quantification of fostemsavir in human plasma and its pharmacokinetic application in rabbits.</p></div><div><h3>Methods</h3><p>Chromatographic separation of the fostemsavir and fosamprenavir (internal standard) were achieved on Zorbax C18 (50 mm × 2 mm × 5 μm) column with 0.80 mL/min flow rate and coupled with API6000 triple quadrupole MS in multi reaction monitoring mode by applying mass transitions <em>m</em>/<em>z</em> 584.16/105.03 for fostemsavir and m/z 586.19/57.07 for the internal standard.</p></div><div><h3>Results</h3><p>The calibration curve exhibited linearity in concentration range of 58.5–2340.0 ng/mL for fostemsavir. The LLOQ was 58.5 ng/mL. The validated LC–MS/MS process was effectively applied for the analysis of plasma in healthy rabbits for determinations of Fostemsavir. From the pharmacokinetic data, the mean of C<sub>max</sub> and T<sub>max</sub> were 198.19 ± 5.85 ng/mL and 2.42 ± 0.13, respectively. Plasma concentration reduced with t<sub>1/2</sub> of 7.02 ± 0.14. AUC<sub>0→Last</sub> value obtained was 2374.87 ± 29.75 ng. h/ml, respectively.</p></div><div><h3>Conclusion</h3><p>In summary, the developed method has been successfully validated and pharmacokinetic parameters were demonstrated after oral administration of Fostemsavir to healthy rabbits.</p></div>\",\"PeriodicalId\":16767,\"journal\":{\"name\":\"Journal of pharmacological and toxicological methods\",\"volume\":\"120 \",\"pages\":\"Article 107254\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmacological and toxicological methods\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1056871923000059\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacological and toxicological methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056871923000059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

摘要

建立了一种新的、灵敏的、特异的LC-MS/MS技术,并验证了其在兔体内的药代动力学应用。方法采用Zorbax C18 (50 mm × 2 mm × 5 μm)色谱柱,流速为0.80 mL/min,采用API6000三极四极质谱联用,以m/z 584.16/105.03和m/z 586.19/57.07为质谱谱,采用多反应监测模式对fostemsavir和fosamprenavir(内标)进行色谱分离。结果本品在58.5 ~ 2340.0 ng/mL范围内具有良好的线性关系。定量限为58.5 ng/mL。经验证的LC-MS /MS方法可有效地用于健康家兔血浆中Fostemsavir的测定。药动学数据显示,Cmax和Tmax的平均值分别为198.19±5.85 ng/mL和2.42±0.13 ng/mL。血药浓度随t1/2(7.02±0.14)降低。AUC0→最后值为2374.87±29.75 ng。分别h /毫升。结论本研究成功验证了该方法的有效性,并对健康家兔口服fostemsaver后的药动学参数进行了验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Validation of an LC–MS/MS method for quantitation of fostemsavir in plasma

Background

A novel, sensitive and specific LC-MS/MS technique was developed and validated for the quantification of fostemsavir in human plasma and its pharmacokinetic application in rabbits.

Methods

Chromatographic separation of the fostemsavir and fosamprenavir (internal standard) were achieved on Zorbax C18 (50 mm × 2 mm × 5 μm) column with 0.80 mL/min flow rate and coupled with API6000 triple quadrupole MS in multi reaction monitoring mode by applying mass transitions m/z 584.16/105.03 for fostemsavir and m/z 586.19/57.07 for the internal standard.

Results

The calibration curve exhibited linearity in concentration range of 58.5–2340.0 ng/mL for fostemsavir. The LLOQ was 58.5 ng/mL. The validated LC–MS/MS process was effectively applied for the analysis of plasma in healthy rabbits for determinations of Fostemsavir. From the pharmacokinetic data, the mean of Cmax and Tmax were 198.19 ± 5.85 ng/mL and 2.42 ± 0.13, respectively. Plasma concentration reduced with t1/2 of 7.02 ± 0.14. AUC0→Last value obtained was 2374.87 ± 29.75 ng. h/ml, respectively.

Conclusion

In summary, the developed method has been successfully validated and pharmacokinetic parameters were demonstrated after oral administration of Fostemsavir to healthy rabbits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of pharmacological and toxicological methods
Journal of pharmacological and toxicological methods PHARMACOLOGY & PHARMACY-TOXICOLOGY
CiteScore
3.60
自引率
10.50%
发文量
56
审稿时长
26 days
期刊介绍: Journal of Pharmacological and Toxicological Methods publishes original articles on current methods of investigation used in pharmacology and toxicology. Pharmacology and toxicology are defined in the broadest sense, referring to actions of drugs and chemicals on all living systems. With its international editorial board and noted contributors, Journal of Pharmacological and Toxicological Methods is the leading journal devoted exclusively to experimental procedures used by pharmacologists and toxicologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信